Propensity score‐based analysis of long‐term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support

AIMS: Left ventricular assist device therapy has become the cornerstone in the treatment of end‐stage heart failure and is increasingly used as destination therapy next to bridge to transplant or recovery. HeartMate 3 (HM3) and HeartWare (HVAD) are centrifugal continuous flow devices implanted intra...

Descripción completa

Detalles Bibliográficos
Autores principales: Numan, Lieke, Ramjankhan, Faiz Z., Oberski, Daniel L., Oerlemans, Martinus I.F.J., Aarts, Emmeke, Gianoli, Monica, Van Der Heijden, Joris J., De Jonge, Nicolaas, Van Der Kaaij, Niels P., Meuwese, Christiaan L., Mokhles, Mostafa M., Oppelaar, Anne‐Marie, De Waal, Eric E.C., Asselbergs, Folkert W., Van Laake, Linda W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006731/
https://www.ncbi.nlm.nih.gov/pubmed/33635573
http://dx.doi.org/10.1002/ehf2.13267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006731/
https://www.ncbi.nlm.nih.gov/pubmed/33635573
http://dx.doi.org/10.1002/ehf2.13267

Ejemplares similares